A batch of COVID-19 vaccines – 698,500 doses of COVISHIELD, the Indian analogue of AstraZeneca/Oxford vaccine – was delivered from India to Tajikistan yesterday night under the COVAX mechanism with the support from UNICEF.
India was the first country to deliver COVID-19 vaccines – 192,000 doses of COVISHILED – to Tajikistan in March 2021 under the COVAX mechanism.
COVISHIELD, manufactured by SIIPL was assessed under the WHO EUL procedure based on the review of data on quality, safety, efficacy, risk management plan (RMP) and programmatic suitability performed by WHO Vaccine Prequalification experts and evaluators from National Regulatory Authorities (NRAs) from different countries and regions.
Tajikistan began COVID-19 vaccination campaign on March 23, 2021.
According to statistical data from the Ministry of Health and Social Protection of the Population (MoHSPP), 6,137,700 doses of five types of vaccines, including COVISHIELD, China’s CoronaVac, Russia’s Sputnik V and the United States’ Moderna and Pfizer, have been delivered to Tajikistan to date.
As of November 30, 3,206,063 (51.8 percent) people in Tajikistan have received the first dose of the COVID-19 vaccine, with 2,590,545 of them (44.5 percent) having received both doses.
Protecting generations: 50 years of the Expanded Programme on Immunization
Emomali Rahmon pays an official visit to Italy and Vatican
Tajik President meets with British Foreign Secretary to discuss cooperation
Tajikistan, United Kingdom sign agreement on air services
New textile enterprise introduced into operation in Dushanbe
Two more hotels commissioned in Dushanbe
UK’s Foreign Secretary visits Tajikistan
Tajikistan reportedly exported about US$7,2 million worth of electricity in the first quarter of this year
Forest ecosystems in GBAO being restored
Representatives of Ukraine and Uzbekistan take the first places in the international half-marathon dedicated to the Tajik Capital City Day
All news
Авторизуйтесь, пожалуйста